PT624375E - Composicoes farmaceuticas contendo hirudina - Google Patents

Composicoes farmaceuticas contendo hirudina

Info

Publication number
PT624375E
PT624375E PT94301083T PT94301083T PT624375E PT 624375 E PT624375 E PT 624375E PT 94301083 T PT94301083 T PT 94301083T PT 94301083 T PT94301083 T PT 94301083T PT 624375 E PT624375 E PT 624375E
Authority
PT
Portugal
Prior art keywords
hydrudine
pharmaceutical compositions
containing pharmaceutical
water
hirudin
Prior art date
Application number
PT94301083T
Other languages
English (en)
Inventor
Tudor Arvinte
Original Assignee
Ucp Gen Pharma Ag
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucp Gen Pharma Ag, Novartis Ag filed Critical Ucp Gen Pharma Ag
Publication of PT624375E publication Critical patent/PT624375E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
PT94301083T 1993-02-18 1994-02-15 Composicoes farmaceuticas contendo hirudina PT624375E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303275A GB9303275D0 (en) 1993-02-18 1993-02-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PT624375E true PT624375E (pt) 2002-08-30

Family

ID=10730651

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94301083T PT624375E (pt) 1993-02-18 1994-02-15 Composicoes farmaceuticas contendo hirudina

Country Status (21)

Country Link
US (1) US5472938A (pt)
EP (1) EP0624375B1 (pt)
JP (1) JP3649343B2 (pt)
CN (1) CN1108137A (pt)
AT (1) ATE216586T1 (pt)
AU (1) AU675471B2 (pt)
CA (1) CA2115815A1 (pt)
DE (1) DE69430458T2 (pt)
DK (1) DK0624375T3 (pt)
ES (1) ES2176222T3 (pt)
FI (1) FI940726A (pt)
GB (1) GB9303275D0 (pt)
HU (1) HUT66079A (pt)
IL (1) IL108610A (pt)
MX (1) MX9401244A (pt)
NO (1) NO940551D0 (pt)
NZ (1) NZ250895A (pt)
PH (1) PH30338A (pt)
PT (1) PT624375E (pt)
TW (1) TW315303B (pt)
ZA (1) ZA941087B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
KR20000070338A (ko) * 1997-01-20 2000-11-25 나가시마 카쭈시게, 노미야마 아키히코 펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
NO20013182L (no) 2000-06-26 2001-12-27 Nokian Tyres Plc System og fremgangsmåte for konvertering og overföring av driftsdata for dekk
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487600A (en) * 1945-10-09 1949-11-08 Sharp & Dohme Inc Aqueous thixotropic gel composition
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
US2987600A (en) * 1959-03-11 1961-06-06 Corning Glass Works Capacitor edge sealing
ZA883443B (en) * 1987-05-21 1988-11-16 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
NZ250895A (en) 1994-06-27
ATE216586T1 (de) 2002-05-15
FI940726A (fi) 1994-08-19
JP3649343B2 (ja) 2005-05-18
IL108610A0 (en) 1994-08-26
HU9400458D0 (en) 1994-05-30
FI940726A0 (fi) 1994-02-16
DE69430458D1 (de) 2002-05-29
IL108610A (en) 1998-03-10
EP0624375A2 (en) 1994-11-17
DE69430458T2 (de) 2002-11-21
AU5508394A (en) 1994-08-25
GB9303275D0 (en) 1993-04-07
EP0624375B1 (en) 2002-04-24
NO940551L (pt) 1994-08-19
DK0624375T3 (da) 2002-07-29
MX9401244A (es) 1994-08-31
JPH06256214A (ja) 1994-09-13
EP0624375A3 (en) 1995-07-19
ZA941087B (en) 1994-08-18
CN1108137A (zh) 1995-09-13
CA2115815A1 (en) 1994-08-19
NO940551D0 (no) 1994-02-17
US5472938A (en) 1995-12-05
ES2176222T3 (es) 2002-12-01
AU675471B2 (en) 1997-02-06
TW315303B (pt) 1997-09-11
HUT66079A (en) 1994-09-28
PH30338A (en) 1997-04-02

Similar Documents

Publication Publication Date Title
SE8303696L (sv) Farmakologiska kompositioner
PT624375E (pt) Composicoes farmaceuticas contendo hirudina
DE69506903D1 (de) Erhöhte solubiliierung von komplexsalzen von methionin mit zink und mangan durch zusatz von ferriionen
IL112389A (en) Freeze dried powder pharmaceutical compositions comprising hirudin
CA2066532A1 (en) Pharmaceutical compositions
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
MY113686A (en) Fungicide mixtures